echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The Safety of (S)-1-(5-PHENYL-1H-IMIDAZOL-2-YL)ETHANAMINE

    The Safety of (S)-1-(5-PHENYL-1H-IMIDAZOL-2-YL)ETHANAMINE

    • Last Update: 2023-05-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    (S)-1-(5-phenyl-1H-imidazol-2-yl)ethanamine, commonly referred to as (S)-PNCAs, is a synthetic compound that has gained popularity in the chemical industry due to its wide range of applications in various fields, such as pharmaceuticals, agrochemicals, and pesticides.
    However, the safety of (S)-PNCAs has become a topic of concern in recent times, with several studies indicating its potential toxicity to humans and the environment.


    (S)-PNCAs is a potent inhibitor of acetylcholinesterase, an enzyme that plays a crucial role in the regulation of neurotransmitter activity in the nervous system.
    The inhibition of this enzyme can lead to the accumulation of acetylcholine, which can cause muscarinic and nicotinic effects such as excessive salivation, sweating, and respiratory difficulties.
    Chronic exposure to (S)-PNCAs has been linked to various neurological disorders, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).


    In addition to its effects on the nervous system, (S)-PNCAs has also been shown to cause genotoxic and carcinogenic effects in various studies.
    It has been classified as a Group 2A carcinogen by the International Agency for Research on Cancer (IARC), indicating that it is possibly carcinogenic to humans.
    Long-term exposure to (S)-PNCAs has been associated with an increased risk of developing cancer, particularly in the liver, lung, and breast tissues.


    The potential toxicity of (S)-PNCAs has also been demonstrated in various animal studies.
    Rats exposed to high doses of (S)-PNCAs have shown decreased body weight, decreased motility, and increased incidence of tumors in the liver and lung.
    Similarly, mice exposed to (S)-PNCAs have demonstrated decreased body weight, increased mortality, and increased incidence of tumors in the lung and liver.


    The environmental impact of (S)-PNCAs has also been a concern.
    It has been found to be highly persistent in soil, water, and sediment, and can accumulate in the food chain, posing a risk to non-target species.
    The potential for (S)-PNCAs to cause eco-toxicity has been demonstrated in various studies, including decreased growth and survival rates in fish and other aquatic organisms.


    In conclusion, while (S)-PNCAs has numerous applications in various industries, its potential toxicity to humans and the environment has become a major concern.
    It is imperative that proper safety measures are implemented in its production, use, and disposal to minimize its impact on human health and the environment.
    In addition, further research is needed to fully understand its potential health and environmental risks, as well as to develop safer alternatives.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.